ICU Medical, Inc.ICUINASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank56
5Y CAGR+11.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+11.2%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.86% |
| Q3 2025 | 405.84% |
| Q2 2025 | -78.16% |
| Q1 2025 | 27.70% |
| Q4 2024 | 11.34% |
| Q3 2024 | -55.95% |
| Q2 2024 | 78.97% |
| Q1 2024 | -49.83% |
| Q4 2023 | 159.57% |
| Q3 2023 | 2485.41% |
| Q2 2023 | -103.57% |
| Q1 2023 | 2510.58% |
| Q4 2022 | -174.10% |
| Q3 2022 | 103.76% |
| Q2 2022 | -4474.14% |
| Q1 2022 | -101.62% |
| Q4 2021 | 4.80% |
| Q3 2021 | 43.96% |
| Q2 2021 | 6.71% |
| Q1 2021 | -34.65% |
| Q4 2020 | 4.03% |
| Q3 2020 | 158.33% |
| Q2 2020 | -26.06% |
| Q1 2020 | -19.12% |
| Q4 2019 | -3.80% |
| Q3 2019 | 118.31% |
| Q2 2019 | 210.75% |
| Q1 2019 | -142.08% |
| Q4 2018 | -2.71% |
| Q3 2018 | -35.59% |
| Q2 2018 | 484.38% |
| Q1 2018 | -124.52% |
| Q4 2017 | -14.37% |
| Q3 2017 | 106.80% |
| Q2 2017 | 162.32% |
| Q1 2017 | -460.78% |
| Q4 2016 | -21.16% |
| Q3 2016 | -0.22% |
| Q2 2016 | 82.57% |
| Q1 2016 | 18.95% |